Cover Image

Safety and Therapeutic Efficacy of Thymoquinone-Loaded Liposomes against Drug-Sensitive and Drug-Resistant <i>Acinetobacter baumannii</i>

In the present study, we investigated the activity of free thymoquinone (TQ) or liposomal thymoquinone (Lip-TQ) in comparison to standard antibiotic amoxicillin (AMX) against the drug-sensitive and drug-resistant <i>Acinetobacter baumannii</i>. A liposomal formulation of TQ was prepared...

Full description

Saved in:

Bibliographic Details
Main Authors:	Khaled S. Allemailem (Author), Abdullah M. Alnuqaydan (Author), Ahmad Almatroudi (Author), Faris Alrumaihi (Author), Aseel Aljaghwani (Author), Habibullah Khalilullah (Author), Hina Younus (Author), Arif Khan (Author), Masood A. Khan (Author)
Format:	Book
Published:	MDPI AG, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and Prophylactic Efficacy of Liposome-Based Vaccine against the Drug-Resistant <i>Acinetobacter baumannii</i> in Mice
by: Masood Alam Khan, et al.
Published: (2022)

Liposomal Ellagic Acid Alleviates Cyclophosphamide-Induced Toxicity and Eliminates the Systemic <i>Cryptococcus neoformans</i> Infection in Leukopenic Mice
by: Masood Alam Khan, et al.
Published: (2021)

Experimental and Theoretical Insights on Chemopreventive Effect of the Liposomal Thymoquinone Against Benzo[a]pyrene-Induced Lung Cancer in Swiss Albino Mice
by: Khan A, et al.
Published: (2022)

Characterization of Extremely Drug-Resistant and Hypervirulent <i>Acinetobacter baumannii</i> AB030
by: Manu Singh, et al.
Published: (2020)

Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Infections
by: Petros Rafailidis, et al.
Published: (2024)

Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Patient Isolates
by: Manas S. Deolankar, et al.
Published: (2022)

Pan-Drug Resistant <i>Acinetobacter baumannii</i>, but Not Other Strains, Are Resistant to the Bee Venom Peptide Melittin
by: Karyne Rangel, et al.
Published: (2020)

Colistin Resistance in <i>Acinetobacter baumannii:</i> Molecular Mechanisms and Epidemiology
by: Katarina Novović, et al.
Published: (2023)

Treatment Strategies of Colistin Resistance <i>Acinetobacter baumannii</i> Infections
by: Andria Papazachariou, et al.
Published: (2024)

<i>Acinetobacter baumannii</i> Infections in Hospitalized Patients, Treatment Outcomes
by: Diaa Alrahmany, et al.
Published: (2021)

Pan-Resistome Insights into the Multidrug Resistance of <i>Acinetobacter baumannii</i>
by: Diego Lucas Neres Rodrigues, et al.
Published: (2021)

DksA Modulates Antimicrobial Susceptibility of <i>Acinetobacter baumannii</i>
by: Nayeong Kim, et al.
Published: (2021)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020)

Investigating Bacteriophages Targeting the Opportunistic Pathogen <i>Acinetobacter baumannii</i>
by: Kathryn M. Styles, et al.
Published: (2020)

Prosthetic valve endocarditis caused by <i> Acinetobacter baumannii </i> complex
by: Kumar S, et al.
Published: (2008)

Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infections: A Drug Pair Limiting the Development of Resistance
by: Junwei Wang, et al.
Published: (2023)

Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against <i>Acinetobacter baumannii</i>
by: Viola Camilla Scoffone, et al.
Published: (2022)

<i>Acinetobacter baumannii</i> Resistance to Sulbactam/Durlobactam: A Systematic Review
by: Luigi Principe, et al.
Published: (2022)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023)

The Role of Uniform Meropenem Usage in <i>Acinetobacter baumannii</i> Clone Replacement
by: Bence Balázs, et al.
Published: (2021)

Antibiotic Resistance and Genotypes of Nosocomial Strains of <i>Acinetobacter baumannii</i> in Kazakhstan
by: Alyona Lavrinenko, et al.
Published: (2021)

Novel Phage Lysin Abp013 against <i>Acinetobacter baumannii</i>
by: Joash Jun Keat Chu, et al.
Published: (2022)

Biofilm-Induced Antibiotic Resistance in Clinical <i>Acinetobacter baumannii</i> Isolates
by: Abebe Mekuria Shenkutie, et al.
Published: (2020)

Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and <i>N</i>-Acetylcysteine against Tobramycin-Resistant <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, and <i>Acinetobacter baumannii</i>
by: Reem E. Alarfaj, et al.
Published: (2022)

The Effect of Liposomal Diallyl Disulfide and Oxaliplatin on Proliferation of Colorectal Cancer Cells: In Vitro and In Silico Analysis
by: Faris Alrumaihi, et al.
Published: (2022)

Exploration of New Drug Candidate Derived from Antioxidants of Korean Native Halophytes: Control of <i>Acinetobacter baumannii</i> with Antipathogenic Activity
by: Jihee Lee, et al.
Published: (2024)

RapidResa Polymyxin <i>Acinetobacter</i> NP<sup>®</sup> Test for Rapid Detection of Polymyxin Resistance in <i>Acinetobacter baumannii</i>
by: Maxime Bouvier, et al.
Published: (2021)

An <i>Acinetobacter</i> non-<i>baumannii</i> Population Study: Antimicrobial Resistance Genes (ARGs)
by: Adam Baraka, et al.
Published: (2020)

Virulence Factors and Pathogenicity Mechanisms of <i>Acinetobacter baumannii</i> in Respiratory Infectious Diseases
by: Yake Yao, et al.
Published: (2023)

Quercetin: Synergistic Interaction with Antibiotics against Colistin-Resistant <i>Acinetobacter baumannii</i>
by: Elif Odabaş Köse, et al.
Published: (2023)

Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant <i>Acinetobacter baumannii</i>
by: Stamatis Karakonstantis, et al.
Published: (2021)

Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Yoon-Jung Choi, et al.
Published: (2024)

The RND Efflux Pump Gene Expression in the Biofilm Formation of <i>Acinetobacter baumannii</i>
by: Ola A. Abd El-Rahman, et al.
Published: (2023)

An Update on the Therapeutic Potential of Antimicrobial Peptides against <i>Acinetobacter baumannii</i> Infections
by: Karyne Rangel, et al.
Published: (2023)

CRISPR-Based Gene Editing in <i>Acinetobacter baumannii</i> to Combat Antimicrobial Resistance
by: Muhammad Junaid, et al.
Published: (2023)

Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in <i>Acinetobacter baumannii</i>
by: Hyejin Cho, et al.
Published: (2023)

Novel Antimicrobial Peptide "Octoprohibitin" against Multidrug Resistant <i>Acinetobacter baumannii</i>
by: E. H. T. Thulshan Jayathilaka, et al.
Published: (2022)

Isolation and Characterisation of Bacteriophage Selective for Key <i>Acinetobacter baumannii</i> Capsule Chemotypes
by: Rosesathorn Soontarach, et al.
Published: (2022)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Tsung-Ying Yang, et al.
Published: (2021)

Acinetobacter baumannii: problemático y además multirresistente Acinetobacter baumannii: problemátic and multiresistant
by: Guillermo PradaTrujillo
Published: (2006)